The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo

被引:0
|
作者
Valerie Reinke
Guillermina Lozano
机构
[1] The University of Texas MD Anderson Cancer Center,Department of Molecular Genetics
来源
Oncogene | 1997年 / 15卷
关键词
apoptosis; p53; targets; ionizing radiation; mice;
D O I
暂无
中图分类号
学科分类号
摘要
The tumor suppressor p53 can exert its anti-oncogenic activity in part by inducing apoptosis in cells that have sustained damage to their DNA. It is likely that p53 activates the transcription of target genes that mediate this response. Known p53 targets with potential roles in cell cycle control and apoptosis induction include: p21WAF1/CIP1, mdm2, cyclin G, bax and Fas. We examined the p53 pathway in the thymus of the mouse after irradiation. FACS analysis demonstrated that the thymocytes of mice with wild-type p53, but not those lacking p53, underwent apoptosis after irradiation. Expression analysis of the target genes revealed that all tested genes underwent p53-dependent induction, although the extent and timing varied. The target genes implicated in cell cycle (p21, mdm2 and cyclin G) were induced 2 h after irradiation, in contrast to targets with a possible role in apoptosis (bax and Fas), which were induced at 4 h. This analysis is the first demonstration that Fas is a p53-responsive gene in vivo. Since p21 and bax expression are not required for p53-dependent apoptosis, we tested whether other target genes affected apoptosis in vivo. We discovered that mdm2 has no role in preventing apoptosis independently of p53 inactivation, and that Fas, like p21 and bax, is not necessary for p53-mediated induction of apoptosis. Therefore, no p53 target identified and tested to date is singly responsible for p53-dependent apoptosis in response to DNA damage in vivo.
引用
收藏
页码:1527 / 1534
页数:7
相关论文
共 50 条
  • [41] P53 α-helix mimetics antagonize p53/MDM2 interaction and activate p53
    Chen, LH
    Yin, H
    Farooqi, B
    Sebti, S
    Hamilton, AD
    Chen, JD
    MOLECULAR CANCER THERAPEUTICS, 2005, 4 (06) : 1019 - 1025
  • [42] MDM2 - arbiter of p53's destruction
    Lane, DP
    Hall, PA
    TRENDS IN BIOCHEMICAL SCIENCES, 1997, 22 (10) : 372 - 374
  • [43] MDM2 chaperones the p53 tumor suppressor
    Wawrzynow, Bartosz
    Zylicz, Alicja
    Wallace, Maura
    Hupp, Ted
    Zylicz, Maciej
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (45) : 32603 - 32612
  • [44] Mdm2 facilitates the association of p53 with the proteasome
    Kulikov, Roman
    Letienne, Justine
    Kaur, Manjit
    Grossman, Steven R.
    Arts, Janine
    Blattner, Christine
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (22) : 10038 - 10043
  • [45] Reactivation of p53 via MDM2 inhibition
    Kim, E. S.
    Shohet, J. M.
    CELL DEATH & DISEASE, 2015, 6 : e1936 - e1936
  • [46] P53 AND MDM2 IMMUNOSTAINING IN PULMONARY BLASTOMAS
    PACINDA, SJ
    LANGSTON, C
    GONDO, MM
    BROWN, RW
    FRANKLIN, RB
    CARMONA, PA
    CAGLE, PT
    LABORATORY INVESTIGATION, 1995, 72 (01) : A151 - A151
  • [47] Mdm2 promotes the rapid degradation of p53
    Ygal Haupt
    Ruth Maya
    Anat Kazaz
    Moshe Oren
    Nature, 1997, 387 : 296 - 299
  • [48] On the biosynthesis of an inhibitor of the p53/MDM2 interaction
    Duncan, SJ
    Williams, DH
    Ainsworth, M
    Martin, S
    Ford, R
    Wrigley, SK
    TETRAHEDRON LETTERS, 2002, 43 (06) : 1075 - 1078
  • [49] RYBP stabilizes p53 by modulating MDM2
    Chen, Deng
    Zhang, Jianbing
    Li, Mao
    Rayburn, Elizabeth R.
    Wang, Hui
    Zhang, Ruiwen
    EMBO REPORTS, 2009, 10 (02) : 166 - 172
  • [50] Mdm2: Keeping p53 under control
    Piette, J
    Neel, H
    Marechal, V
    ONCOGENE, 1997, 15 (09) : 1001 - 1010